The Study of the Prevention of Anal Cancer (SPANC): design and methods of a three-year prospective cohort study
Open Access
- 9 October 2013
- journal article
- Published by Springer Science and Business Media LLC in BMC Public Health
- Vol. 13 (1), 946
- https://doi.org/10.1186/1471-2458-13-946
Abstract
The incidence of human papillomavirus (HPV)-associated anal cancer is increasing in men who have sex with men (MSM). Screening for the presumed cancer precursor, high-grade anal squamous intraepithelial lesions (HSIL) in a manner analogous to cervical cancer screening has been proposed. Uncertainty remains regarding anal HPV natural history and the role of anal cytology and high-resolution anoscopy (HRA) as screening tests. Well-designed cohort studies are required to address these issues. The SPANC study is a prospective study of the epidemiology of low-risk and high-risk anal HPV infection and related cytological and histological abnormalities in HIV-negative and HIV-positive homosexual men aged 35 years and over. The study aims to recruit 600 men from community-based settings in Sydney, Australia. There are six study visits over three years. At the first five visits men undergo a digital ano-rectal examination (DARE), an anal "Papanicolaou" (Pap) test for HPV detection, genotyping and anal cytology, followed by HRA and directed biopsy of any visible abnormalities. The men also complete a behavioural questionnaire before each visit. Questions include a detailed history of sexual behaviour, of anal symptoms, possible anal cancer risk factors and validated quality of life and psychosocial questions. Questionnaires are also completed 2 weeks and 3 months following the provision of test results and include questions on participant experience during the procedure and post-procedure symptoms, including pain and bleeding in addition to quality of life/ psychosocial outcomes. Recruitment for the study began in September 2010 and will conclude in mid-2015, with follow up continuing to 2018. Thus far, over 350 men have been recruited from a variety of community-based settings and are broadly representative of the target screening population. The SPANC study is one of only a small number of cohort studies globally to perform HPV, cytology and HRA screening on all participants over multiple time points. The study results will contribute to understanding of the natural history of anal HPV and inform the possible development of guidelines for implementing anal cancer screening programs in this population.Keywords
This publication has 36 references indexed in Scilit:
- Risk of Anal Cancer in HIV-Infected and HIV-Uninfected Individuals in North AmericaClinical Infectious Diseases, 2012
- The epidemiology of anal cancerSexual Health, 2012
- Practising high-resolution anoscopySexual Health, 2012
- HPV Vaccine against Anal HPV Infection and Anal Intraepithelial NeoplasiaThe New England Journal of Medicine, 2011
- P16/CDKN2A and Ki-67 Enhance the Detection of Anal Intraepithelial Neoplasia and Condyloma and Correlate With Human Papillomavirus Detection by Polymerase Chain ReactionThe American Journal of Surgical Pathology, 2010
- Effect of ThinPrep Preparation on Human papillomavirus Detection and Genotyping in Rectal Samples by PCRJournal of Clinical Microbiology, 2009
- Cohort Profile: The 45 and Up StudyInternational Journal of Epidemiology, 2007
- The Use of Rectal Douches among HIV-uninfected and Infected Men who Have Unprotected Receptive Anal Intercourse: Implications for Rectal MicrobicidesAIDS and Behavior, 2007
- Psychological consequences of positive results in cervical cancer screeningPsychology & Health, 1995
- Sexual Practices, Sexually Transmitted Diseases, and the Incidence of Anal CancerThe New England Journal of Medicine, 1987